Skip to Main Content

Author Details

Dominik Sturm
Hopp Children's Cancer Center Heidelberg (KiTZ)
2008
99
46
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37875569Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2024
37875569Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2024
36928815Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2023
36437415Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
37851269Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.Acta Neuropathol2023
36715306Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.Neuro Oncol2023
36959034Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84].Eur J Cancer2023
37188167Clinical outcome following surgical resection and radiotherapy in adult patients with pleomorphic xanthoastrocytoma as defined by DNA methylation profiling.Neurooncol Pract2023
37379234Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.Neuro Oncol2023
36542877Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry.Eur J Cancer2023
36928815Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.Nat Med2023
36459208Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.Acta Neuropathol2023
36786841Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
37517472Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study.J Mol Diagn2023
37851269Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.Acta Neuropathol2023
37517472Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study.J Mol Diagn2023
36959034Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84].Eur J Cancer2023
37188167Clinical outcome following surgical resection and radiotherapy in adult patients with pleomorphic xanthoastrocytoma as defined by DNA methylation profiling.Neurooncol Pract2023
37379234Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.Neuro Oncol2023
36786841Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
36715306Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.Neuro Oncol2023
36542877Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry.Eur J Cancer2023
36437415Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
36459208Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.Acta Neuropathol2023
34699462Cui Bono? Identifying Patient Groups That May Benefit From Granulocyte Transfusions in Pediatric Hematology and Oncology.J Pediatr Hematol Oncol2022
36070143Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinases.Acta Neuropathol2022
35603902Changing paradigms in oncology: Toward noncytotoxic treatments for advanced gliomas.Int J Cancer2022
35660939DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma.Acta Neuropathol2022
34674226Primary central nervous system sarcoma with DICER1 mutation-treatment results of a novel molecular entity in pediatric Peruvian patients.Cancer2022
35195346ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant.Pediatr Blood Cancer2022
35190934Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies.J Neurooncol2022
35012690Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival.Acta Neuropathol Commun2022
34699462Cui Bono? Identifying Patient Groups That May Benefit From Granulocyte Transfusions in Pediatric Hematology and Oncology.J Pediatr Hematol Oncol2022
35053437A Systematic Review and Meta-Analysis of Malignant Rhabdoid and Small Cell Undifferentiated Liver Tumors: A Rational for a Uniform Classification.Cancers (Basel)2022
35603902Changing paradigms in oncology: Toward noncytotoxic treatments for advanced gliomas.Int J Cancer2022
35660939DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma.Acta Neuropathol2022
36070143Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinases.Acta Neuropathol2022
35190934Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies.J Neurooncol2022
35012690Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival.Acta Neuropathol Commun2022
35053437A Systematic Review and Meta-Analysis of Malignant Rhabdoid and Small Cell Undifferentiated Liver Tumors: A Rational for a Uniform Classification.Cancers (Basel)2022
35195346ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant.Pediatr Blood Cancer2022
34674226Primary central nervous system sarcoma with DICER1 mutation-treatment results of a novel molecular entity in pediatric Peruvian patients.Cancer2022
33479225Sarcoma classification by DNA methylation profiling.Nat Commun2021
34077956Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.Neuro Oncol2021
33479225Sarcoma classification by DNA methylation profiling.Nat Commun2021
33879448Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas.Cancer Discov2021
34355256Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors.Acta Neuropathol2021
33130881A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR.Neuro Oncol2021
33336421Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing data.Neuropathol Appl Neurobiol2021
33216206Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.Acta Neuropathol2021
  • 1 - 50 of 198

Recommended Authors

Frauke-Dorothee Meyer
German Cancer Research Center (DKFZ)
Career Start Year 2018
Number of shared co-authors 30
David Pauck
German Cancer Research Center (DKFZ)
Career Start Year 2017
Number of shared co-authors 22
Edgar Sioson
St. Jude Children's Research Hospital
Career Start Year 2017
Number of shared co-authors 19
Katherine E Miller
College of Medicine, The Ohio State University
Career Start Year 2017
Number of shared co-authors 4
Sibo Zhao
Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine
Career Start Year 2016
Number of shared co-authors 5
Chelsea Mayoh
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2016
Number of shared co-authors 45
Juan C Vasquez
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Patryk Skowron
University of Toronto
Career Start Year 2015
Number of shared co-authors 68
Jennifer A Cotter
Children's Hospital Los Angeles
Career Start Year 2014
Number of shared co-authors 21
Calixto-Hope G Lucas
University of California San Francisco
Career Start Year 2014
Number of shared co-authors 15
Jaime M Guidry Auvil
National Cancer Institute
Career Start Year 2013
Number of shared co-authors 13
Krutika S Gaonkar
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2012
Number of shared co-authors 11
Ashley Margol
Children's Hospital Los Angeles
Career Start Year 2010
Number of shared co-authors 37
Xin Wang
The Chinese University of Hong Kong, Prince of Wales Hospital
Career Start Year 2010
Number of shared co-authors 82
Carl Koschmann
University of Michigan-Ann Arbor
Career Start Year 2010
Number of shared co-authors 41
Payal Jain
Maharaja Agrasen Medical College
Career Start Year 2009
Number of shared co-authors 25
Adrian M Dubuc
Dana-Farber Cancer Institute
Career Start Year 2008
Number of shared co-authors 83
Claudia C Faria
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Career Start Year 2008
Number of shared co-authors 107
Cassie Kline
Children's Hospital of Philadelphia
Career Start Year 2008
Number of shared co-authors 35
Roel G W Verhaak
Yale School of Medicine
Career Start Year 2004
Number of shared co-authors 35
Mario L Suv??
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 38
Alessandro Raso
Giannina Gaslini Institute
Career Start Year 2003
Number of shared co-authors 27
Ga??lle Pierron
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 23
Brian R Rood
Brain Tumor Institute, Children's National Hospital
Career Start Year 1998
Number of shared co-authors 54
Rajeev Vibhakar
Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Career Start Year 1997
Number of shared co-authors 80
Rishi R Lulla
Hasbro Children's Hospital, Brown University.
Career Start Year 1997
Number of shared co-authors 56
Donald W Parsons
Texas Children's Hospital
Career Start Year 1996
Number of shared co-authors 46
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 20
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year 1990
Number of shared co-authors 52
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 52

Collaborators

Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 80
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 67
Andreas von Deimling
Co-authored papers 61
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 56
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 44
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 39
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 33
Till Milde
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 32
Martin Sill
Co-authored papers 30
David Capper
Charite University Medicine Berlin
Co-authored papers 28
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers 28
Christof M Kramm
Co-authored papers 27
Stefan Rutkowski
University Medical Center Hamburg-Eppendorf
Co-authored papers 26
Ulrich Sch??ller
University Medical Center Hamburg-Eppendorf
Co-authored papers 24
Torsten Pietsch
Co-authored papers 24
Marina Ryzhova
N.N. Burdenko Neurosurgical Institute
Co-authored papers 23
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 23
Christel Herold-Mende
Co-authored papers 20
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers 18
Andreas E Kulozik
Co-authored papers 18
Guido Reifenberger
Heinrich Heine University
Co-authored papers 18
Michael D Taylor
The Hospital for Sick Children
Co-authored papers 17
Katja von Hoff
Co-authored papers 15
Hendrik Witt
Co-authored papers 15
Andreas Unterberg
Co-authored papers 14
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 13
André O von Bueren
Co-authored papers 13
Andrea Wittmann
Co-authored papers 13
Kristian W Pajtler
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Co-authored papers 12
Michael C Frühwald
Co-authored papers 12
Release 1.2